Nanobiotix Joins Euronext Tech Leaders Segment: Enhanced Visibility Among International Investors
French biotech company Nanobiotix announced on Tuesday its inclusion in the Euronext Tech Leaders segment and the corresponding index, an initiative launched by Euronext in 2022 to promote innovative and growing technology companies to international investors.
Recognition of Leadership in Physical and Nanotechnology Innovation
This inclusion reflects Nanobiotix's positioning at the intersection of nanotechnology, physics, and medicine, as the company develops a portfolio of nano-therapeutic platforms based on physics, aimed at addressing significant unmet medical needs. Laurent Levy, CEO and Chairman of the Executive Board of Nanobiotix, stated that this recognition underscores the progress made by the company and the broader potential of physics-based innovation to significantly contribute to the future of healthcare.
Benefits of Membership in the Euronext Program
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Members of the Euronext Tech Leaders segment enjoy increased visibility among international investors, access to a broad network of market participants, and participation in events and initiatives designed to support long-term growth. Based in Paris and listed on Euronext since 2012, Nanobiotix also has a subsidiary in Cambridge, Massachusetts, and has been listed on the Nasdaq since December 2020.
SectorSanté · Biotechnologies · Vaccins et laboratoires de recherche›Biotechnologie
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
